GlassScriptPhysician profile
Lindsey E Murrill
NPI 1396134250
$512.94
in general payments reported to CMS, 2019-2025
10 companies · $94.60 in 2025
The $94.60 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.03 · 2022: $75.82 · 2023: $140 · 2024: $171 · 2025: $94.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $206.97 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $99.35 | 2023-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $49.86 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $41.49 | 2025 | Watchman Flx |
| Amgen INC. | $31.06 | 2021-2023 | Repatha |
| Abbott Laboratories | $18.22 | 2024 | Jot Dx |
| Esperion Therapeutics, INC. | $17.36 | 2024 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.70 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $16.39 | 2022 | |
| Gilead Sciences, INC. | $15.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Murrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.